IL1B and Heat Stroke: The immediate systemic treatment with the combined agent (both DXM and HES), in addition to attenuating the elevating levels of IL-1β, TNF-α and MDA in blood stream, diminishes monoamines, glutamate, and hydroxyl radical formation, and ischemia injury in the brain, and improves ST in rats with heat stroke.